Complication of Prematurity
10
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (10)
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Early Intervention Program for Preterm Infants and Their Parents: Establishing the Impact at 18 Months Corrected Age
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
The Preterm Infants' Paracetamol Study
Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
Effects of Parenteral L-carnitine Supplementation in Premature Neonates
Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
Patterned Experience for Preterm Infants